Dubrey S W, Sharma R, Underwood R, Mittal T
Department of Cardiology, Hillingdon Hospital, Uxbridge, UK.
Department of Cardiology, The Royal Brompton Hospital, London, UK.
Postgrad Med J. 2015 Jul;91(1077):384-94. doi: 10.1136/postgradmedj-2014-133219. Epub 2015 Jun 30.
Cardiac sarcoidosis is one of the most serious and unpredictable aspects of this disease state. Heart involvement frequently presents with arrhythmias or conduction disease, although myocardial infiltration resulting in congestive heart failure may also occur. The prognosis in cardiac sarcoidosis is highly variable, which relates to the heterogeneous nature of heart involvement and marked differences between racial groups. Electrocardiography and echocardiography often provide the first clue to the diagnosis, but advanced imaging studies using positron emission tomography and MRI, in combination with nuclear isotope perfusion scanning are now essential to the diagnosis and management of this condition. The identification of clinically occult cardiac sarcoidosis and the management of isolated and/or asymptomatic heart involvement remain both challenging and contentious. Corticosteroids remain the first treatment choice with the later substitution of immunosuppressive and steroid-sparing therapies. Heart transplantation is an unusual outcome, but when performed, the results are comparable or better than heart transplantation for other disease states. We review the epidemiology, developments in diagnostic techniques and the management of cardiac sarcoidosis.
心脏结节病是这种疾病状态中最严重且最不可预测的方面之一。心脏受累常表现为心律失常或传导系统疾病,尽管也可能发生导致充血性心力衰竭的心肌浸润。心脏结节病的预后差异很大,这与心脏受累的异质性以及不同种族群体之间的显著差异有关。心电图和超声心动图常常为诊断提供首个线索,但如今,正电子发射断层扫描和磁共振成像等先进影像学检查,结合核素灌注扫描,对于这种疾病的诊断和管理至关重要。识别临床隐匿性心脏结节病以及管理孤立性和/或无症状性心脏受累仍然既具有挑战性又存在争议。皮质类固醇仍然是首选治疗药物,随后可改用免疫抑制和类固醇节省疗法。心脏移植是一种不常见的结局,但进行心脏移植时,其结果与其他疾病状态的心脏移植相当或更好。我们综述了心脏结节病的流行病学、诊断技术进展及治疗方法。